Market Report
London open: Stocks little changed amid deluge of earnings; Trump eyed
Stocks in London were little changed in early trade on Tuesday as investors sifted through a deluge of corporate news and looked ahead to US President Donald Trump's address to Congress later in the day.
AstraZeneca wins approval for adult type-2 diabetes treatment
AstraZeneca has been given a green light by US drug regulators for its once-daily treatment of type-2 diabetes, called Qtern.
Fresnillo more than doubles profits after record gold, silver production
Miner Fresnillo gave an upbeat outlook for this year after more than doubling its profits in 2016 as revenues surged due to record gold and silver production, high precious metals prices and the devaluation of the Mexican peso against the dollar.
Fresnillo more than doubles profits, Babcock remains in line
London open The FTSE 100 is predicted to edge around eight points higher on Tuesday, according to pre-market trading.
GKN full-year profit up 12% as sales rise
FTSE 100 engineer GKN posted a 12% jump in full-year pre-tax profit as sales rose and the company expressed confidence over its prospects for 2017.
London pre-open: Stocks seen higher as investors eye Trump speech
Stocks in London were set to open higher, taking their cue from a positive session on Wall Street where the Dow notched its 12th consecutive record close, as investors looked ahead to US President Donald Trump's address to Congress later in the day.